|
US2019048049A1
|
|
Cargomers
|
|
US2019046608A1
|
|
Apomers
|
|
PH12018500508A1
|
|
Methods for the synthesis of spingomyelins and dihydrosphingomyelins
|
|
WO2018029505A1
|
|
Cer-001 therapy for treating familial primary hypoalphalipoproteinemia
|
|
AU2016203507A1
|
|
Compounds, compositions and methods useful for cholesterol mobilisation
|
|
AU2015271986A1
|
|
Lipoprotein complexes and manufacturing and uses thereof
|
|
AU2015227476A1
|
|
Compounds, compositions and methods useful for cholesterol mobilisation
|
|
KR20170003611A
|
|
Hdl therapy markers
|
|
AU2014268255A1
|
|
Apolipoprotein a-i mimics
|
|
SG11201506456VA
|
|
Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
|
|
US2014275590A1
|
|
Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
|
|
AU2012202223A1
|
|
Charged lipoprotein complexes and their uses
|
|
RS56529B1
|
|
Compounds, compositions and methods useful for cholesterol mobilisation
|
